Big investment push: Sun Pharma Labs to set up Rs 3000 crore facility in MP
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-12-03 07:00 GMT | Update On 2025-12-03 07:00 GMT
Advertisement
Mumbai: Sun Pharma Laboratories Limited, a wholly owned subsidiary of Sun Pharma, is set to establish a Rs 3,000-crore greenfield formulations manufacturing facility in Madhya Pradesh.
The company confirmed that the proposal for the investment to set up the facility has been formally approved by the Board of Directors of Sun Pharma Laboratories.
In a separate development, Medical Dialogues team reported last month reported that Sun Pharma has kept its options open on enhancing its manufacturing footprint in the U.S., even as the U.S. administration's 100% tariff on branded and patented medicines has created uncertainty for global drugmakers.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.